Literature DB >> 25403265

Alterations of T helper lymphocyte subpopulations in sepsis, severe sepsis, and septic shock: a prospective observational study.

Jia Li1, Ming Li, Longxiang Su, Huijuan Wang, Kun Xiao, Jie Deng, Yanhong Jia, Gencheng Han, Lixin Xie.   

Abstract

Circulating lymphocyte number was significantly decreased in patients with sepsis. However, it remains unknown which severity phase (sepsis, severe sepsis, and septic shock) does it develop and what happen on each subpopulation. Eight patients with differing severities of sepsis (31 sepses, 33 severe sepses, and 16 septic shocks) were enrolled. Quantitative real-time polymerase chain reaction (RT-PCR) of Th1, Th2, and Th17; regulatory T (Treg) cell-specific transcription factor T-bet; GATA-3; RORgammat (RORγt); forkhead box P3 (FOXP3); and IL-17 mRNA were performed, and the enzyme-linked immunosorbent assay (ELISA) was used to detect serum interferon (IFN)-γ, IL-4, and IL-10. In this study, the Th1, Th2, Treg transcription factors, and related cytokines IFN-γ, IL-4, and IL-10 levels of sepsis and severe sepsis patients in peripheral blood were significantly higher than those of the normal controls. Except for IL-17, the T-bet, GATA-3, and IFN-γ levels of septic shock patients were lower than those of sepsis patients. We also observed that the proportions of Th17/Treg in the sepsis and septic shock groups were inversed. From the above, the inflammatory response especially the adaptive immune response is still activated in sepsis and severe sepsis, but significant immunosuppression was developed in septic shock. In addition, the proportion of Th17/Treg inversed may be associated with the illness aggravation of patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25403265     DOI: 10.1007/s10753-014-0063-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Early assessment of leukocyte alterations at diagnosis of septic shock.

Authors:  Fabienne Venet; Fanny Davin; Caroline Guignant; Audrey Larue; Marie-Angélique Cazalis; Romain Darbon; Caroline Allombert; Bruno Mougin; Christophe Malcus; Françoise Poitevin-Later; Alain Lepape; Guillaume Monneret
Journal:  Shock       Date:  2010-10       Impact factor: 3.454

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

5.  Th17 and Treg cells, two new lymphocyte subpopulations with a key role in the immune response against infection.

Authors:  Rolando Vernal; Jose A Garcia-Sanz
Journal:  Infect Disord Drug Targets       Date:  2008-12

6.  Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice.

Authors:  Markus Bosmann; Fabien Meta; Robert Ruemmler; Mikel D Haggadone; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2013-04       Impact factor: 4.307

7.  Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.

Authors:  Satoshi Ono; Akifumi Kimura; Shuhichi Hiraki; Risa Takahata; Hironori Tsujimoto; Manabu Kinoshita; Hiromi Miyazaki; Junji Yamamoto; Kazuo Hase; Daizoh Saitoh
Journal:  Surgery       Date:  2012-08-09       Impact factor: 3.982

8.  Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis.

Authors:  Milena Karina Colo Brunialti; Michelle Carolina Santos; Otelo Rigato; Flavia Ribeiro Machado; Eliezer Silva; Reinaldo Salomao
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834

10.  Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis.

Authors:  Huang-Pin Wu; Kong Chung; Chun-Yao Lin; Bor-Yiing Jiang; Duen-Yau Chuang; Yu-Chih Liu
Journal:  Inflamm Res       Date:  2013-05-14       Impact factor: 4.575

View more
  21 in total

1.  Anti-Asthmatic Effects of Ginsenoside Rb1 in a Mouse Model of Allergic Asthma Through Relegating Th1/Th2.

Authors:  Tong Chen; Lu Xiao; Lingpeng Zhu; Shiping Ma; Tianhua Yan; Hui Ji
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  Partial Depletion of Regulatory T Cells Enhances Host Inflammatory Response Against Acute Pseudomonas aeruginosa Infection After Sepsis.

Authors:  Zhi-Qiang Hu; Yong-Ming Yao; Wei Chen; Jia-Lan Bian; Lin-Jun Zhao; Long-Wang Chen; Guang-Liang Hong; Zhong-Qiu Lu; Guang-Ju Zhao
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

4.  Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection.

Authors:  Patricia Bartsch; Christoph Kilian; Malte Hellmig; Hans-Joachim Paust; Alina Borchers; Amirrtavarshni Sivayoganathan; Leon Enk; Yu Zhao; Nikhat Shaikh; Henning Büttner; Milagros N Wong; Victor G Puelles; Thorsten Wiech; Richard Flavell; Tobias B Huber; Jan-Eric Turner; Stefan Bonn; Samuel Huber; Nicola Gagliani; Hans-Willi Mittrücker; Holger Rohde; Ulf Panzer; Christian F Krebs
Journal:  PLoS Pathog       Date:  2022-04-21       Impact factor: 6.823

Review 5.  Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression.

Authors:  Chao Ren; Hui Zhang; Tian-Tian Wu; Yong-Ming Yao
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

6.  Assessment of interleukin-17A, C5a and RANTES for early diagnosis of neonatal sepsis - a preliminary study.

Authors:  Beata Kasztelewicz; Ewa Piotrowska; Justyna Tołłoczko; Maria K Borszewska-Kornacka; Hanna Gregorek; Katarzyna Dzierżanowska-Fangrat
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

7.  T-Bet Expression Mediated by the mTOR Pathway Influences CD4+ T Cell Count in Mice With Lethal Candida Sepsis.

Authors:  Guangxu Bai; Hao Wang; Wen Han; Na Cui
Journal:  Front Microbiol       Date:  2020-05-05       Impact factor: 5.640

8.  Early Changes in Circulatory T Helper Type 1, 2, and 17 Cells of Patients with Out-of-Hospital Cardiac Arrest after Successful Cardiopulmonary Resuscitation.

Authors:  Zhi-Jiang Qi; Qiang Zhang; Bo Liu; Huan Shao; Chun-Sheng Li
Journal:  Chin Med J (Engl)       Date:  2018-09-05       Impact factor: 2.628

9.  Early and dynamic alterations of Th2/Th1 in previously immunocompetent patients with community-acquired severe sepsis: a prospective observational study.

Authors:  Ming Xue; Jianfeng Xie; Ling Liu; Yingzi Huang; Fengmei Guo; Jingyuan Xu; Yi Yang; Haibo Qiu
Journal:  J Transl Med       Date:  2019-02-27       Impact factor: 5.531

10.  Increased mortality in CD43-deficient mice during sepsis.

Authors:  Katherine T Fay; Deena B Chihade; Ching-Wen Chen; Nathan J Klingensmith; John D Lyons; Kimberly Ramonell; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.